First Opinion

First Opinion

Ghost networks of psychiatrists make money for insurance companies but hinder patients’ access to care

By Jack Turban

First Opinion

Quitting smoking is hard. Mindfulness hacks the habit loop, offering a new approach

By Jud Brewer

First Opinion

Cost-cutting jeopardizes many Americans’ access to lifesaving oxygen therapy

By Brian Block and Neeta Thakur

First Opinion

Why I believe the Warren-Cummings CARE Act can stop people like me from becoming opioid overdose statistics

By Ryan Hampton

First Opinion

Ebola vaccine for pregnant women: one step closer but still more to go

By Sonja A. Rasmussen and Denise J. Jamieson

First Opinion

How will we pay for the coming generation of potentially curative gene therapies?

By Bill Cassidy

First Opinion

Stories are the currency of medicine

By Zachary G. Jacobs

First Opinion

Industry-funded attacks on the CDC’s opioid prescribing guideline are eroding public health

By Ben Goodwin, Judy Butler, and Adriane Fugh-Berman

First Opinion

Doctors: use social media with restraint

By Daniel Sokol

First Opinion

Appeals court’s smart move paves the way for opioid addiction treatment in prisons and jails

By Kevin Doyle

Opinions Plus

Biomarkers provide a bridge to the next frontier in immuno-oncology

By Grey Wilkinson

First Opinion

Genetic testing: the next big arena for fraud?

By Bob Thomas

First Opinion

Proposed patent legislation would block research, stifle innovation, and harm patients

By Othman Laraki

First Opinion

As Americans shun the measles vaccine, the residents of Idjwi are dying to get it

By Jacques Sebisaho

First Opinion

DiMe: Calling all who serve in digital medicine

By Jen Goldsack, Beau Woods, and Eric Perakslis

First Opinion

Creating eggs and sperm from stem cells: the next big thing in assisted reproduction?

By I. Glenn Cohen and Alex Pearlman

Opinions Plus

How to apply real-world evidence to outsmart cancer

By Christopher Boone and Viraj Narayanan

First Opinion

Hiding in plain sight: The FDA’s approach to disclosing new drug applications is a disservice to public health

By Peter G. Lurie

First Opinion

Pregnant women with substance use disorders need treatment, not prison

By Marty Jessup

First Opinion

‘Anchoring’ was at work in setting the price of Novartis’ new gene therapy

By Peter B. Bach

First Opinion

The shortage of haloperidol, an ‘old’ drug, haunts me

By Maya Gottfried

President Trump Signs "Right To Try" Act

First Opinion

‘Right-to-try’ laws provide little access to investigational drugs. We created a process that does

By Arthur Caplan

First Opinion

I have spinal muscular atrophy. Critics of the $2 million new gene therapy are missing the point

By Nathan Yates

First Opinion

How my PTSD changed the way I care for pregnant women

By Shivani Patel

First Opinion

Access to medical cannabis: a new health care disparity

By Julia Arnsten

Working together, data scientists and cancer researchers can transform cancer treatment

Hospitals are a missing link in easing the opioid crisis

As global markets for generic drugs fail, poor people pay the price

Shopping blindly for post-acute care is a recipe for disaster

Ghost networks of psychiatrists make money for insurance companies but hinder patients’ access to care

Quitting smoking is hard. Mindfulness hacks the habit loop, offering a new approach

Cost-cutting jeopardizes many Americans’ access to lifesaving oxygen therapy

Why I believe the Warren-Cummings CARE Act can stop people like me from becoming opioid overdose statistics

Ebola vaccine for pregnant women: one step closer but still more to go

How will we pay for the coming generation of potentially curative gene therapies?

Stories are the currency of medicine

Industry-funded attacks on the CDC’s opioid prescribing guideline are eroding public health

Doctors: use social media with restraint

Appeals court’s smart move paves the way for opioid addiction treatment in prisons and jails

Biomarkers provide a bridge to the next frontier in immuno-oncology

Genetic testing: the next big arena for fraud?

Proposed patent legislation would block research, stifle innovation, and harm patients

As Americans shun the measles vaccine, the residents of Idjwi are dying to get it

DiMe: Calling all who serve in digital medicine

Creating eggs and sperm from stem cells: the next big thing in assisted reproduction?

How to apply real-world evidence to outsmart cancer

Hiding in plain sight: The FDA’s approach to disclosing new drug applications is a disservice to public health

Pregnant women with substance use disorders need treatment, not prison

‘Anchoring’ was at work in setting the price of Novartis’ new gene therapy

The shortage of haloperidol, an ‘old’ drug, haunts me

‘Right-to-try’ laws provide little access to investigational drugs. We created a process that does

I have spinal muscular atrophy. Critics of the $2 million new gene therapy are missing the point

How my PTSD changed the way I care for pregnant women

Access to medical cannabis: a new health care disparity

First Opinion

Sign up for our Daily Recap newsletter